News + Filings Transactions
|
Tananbaum James B.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/08/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 229k | $2.80 | $641.3k | See Footnote | 05/08/2023 |
05/08/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 1.6M | $2.80 | $4.3M | See Footnote | 05/08/2023 |
02/17/2023 | Kinnate Biopharma Inc. | | Other (acquisition) | Common Stock | 1.1M | $0.00 | $0 | See Footnote | 02/17/2023 |
06/13/2022 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 20.2k | $8.38 | $169.7k | | 06/13/2022 |
06/08/2022 | PARDES BIOSCIENCES, INC. | | Grant | Stock Option (Right to Buy) | 37.5k | $5.21 | $195.4k | | 06/08/2022 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Footnote | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Footnote | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Grant | Stock Option (right to buy) | 75k | $9.80 | $735k | | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Grant | Common Stock | 1000k | $10.00 | $10M | See Footnote | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Footnote | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Grant | Common Stock | 7.8M | $0.00 | $0 | See Footnote | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Footnote | 12/23/2021 |
12/23/2021 | PARDES BIOSCIENCES, INC. | | Grant | Stock Option (right to buy) | 75k | $9.80 | $735k | | 12/23/2021 |
12/22/2021 | PARDES BIOSCIENCES, INC. | | Purchase | Common Stock | 325k | $10.00 | $3.2M | See Footnote | 12/22/2021 |
10/04/2021 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 17.2k | $3.80 | $65.5k | | 10/04/2021 |
06/11/2021 | Quantum-Si Inc | | Grant | Class A Common Stock | 20.5k | $0.00 | $0 | | 06/10/2021 |
06/10/2021 | Quantum-Si Inc | | Grant | Class A Common Stock | 348.1k | $0.00 | $348.1 | Foresite Capital Fund V, L.P. | 06/10/2021 |
06/10/2021 | Quantum-Si Inc | | Grant | Class A Common Stock | 4.5M | $0.00 | $0 | Foresite Capital Fund IV, L.P. | 06/10/2021 |
06/10/2021 | Quantum-Si Inc | | Grant | Class A Common Stock | 743.9k | $0.00 | $0 | Foresite Capital Fund V, L.P. | 06/10/2021 |
06/10/2021 | Quantum-Si Inc | | Grant | Class A Common Stock | 1.2M | $10.00 | $12.5M | Foresite Capital Fund V, L.P. | 06/10/2021 |
02/05/2021 | Disc Medicine, Inc. | | Grant | Common Stock | 1.5M | $10.00 | $15M | See Footnote | 02/05/2021 |
02/05/2021 | Disc Medicine, Inc. | | Conversion | Common Stock | 2.9M | $0.00 | $0 | See Footnote | 02/05/2021 |
02/05/2021 | Disc Medicine, Inc. | | Conversion | Common Stock | 2.9M | $0.00 | $0 | See Footnote | 02/05/2021 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series C Preferred Stock | 48.4k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Common Stock | 9.2M | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Common Stock | 500k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Common Stock | 166.7k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series A Preferred Stock | 6.3M | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series A Preferred Stock | 298.5k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series A Preferred Stock | 99.5k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series B Preferred Stock | 2.7M | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series B Preferred Stock | 55.9k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series B Preferred Stock | 18.6k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series C Preferred Stock | 157.2k | $0.00 | $0 | See footnote | 12/07/2020 |
12/07/2020 | Kinnate Biopharma Inc. | | Conversion | Series C Preferred Stock | 145.1k | $0.00 | $0 | See footnote | 12/07/2020 |
|
|